Cargando…
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery
Medulloblastoma (MB) is one of the most frequent and malignant brain tumors in children. The prognosis depends on the advancement of the disease and the patient’s age. Current therapies, which include surgery, chemotherapy, and irradiation, despite being quite effective, cause significant side effec...
Autores principales: | Strejczek, Agata, Woszczyk, Dawid, Urbaniak, Helena, Różańska, Martyna, Robak, Michał, Matuszewska, Zofia, Barciszewska, Anna-Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124462/ https://www.ncbi.nlm.nih.gov/pubmed/34066495 http://dx.doi.org/10.3390/ijms22094925 |
Ejemplares similares
-
Taking a chance on epigenetics
por: Lelièvre, Sophie A.
Publicado: (2014) -
Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017) -
The advent of precision epigenetics for medulloblastoma
por: Li, Chaoxi, et al.
Publicado: (2020) -
Epigenetics and immune cells in medulloblastoma
por: Gorini, Francesca, et al.
Publicado: (2023) -
Active 5΄ splice sites regulate the biogenesis efficiency of Arabidopsis microRNAs derived from intron-containing genes
por: Knop, Katarzyna, et al.
Publicado: (2017)